臨床試驗動向 Vol.2：商業策略

臨床試驗動向 Vol.2：商業策略 是由出版商Trimark Publications在2010年09月所出版的。 這份英文市場調查報告書包含117 pages 價格從美金1999起跳。

簡介

本報告，針對美國以及全球臨床試驗室的商業部門相關的規模與成長率、與各種機關的合作、臨床試驗室未來的新商業策略等進行檢視，由下列摘要形式闡述。

第1章 概要

• 報告的目的
• 方法
• 報告的範圍
• 報告摘要

第2章 IVD臨床試驗市場

• 簡介
• 獨立式試驗室的主要參與機關
• 醫療臨床試驗室服務投資動向

第3章 臨床試驗室市場

• 美國市場
• 主要企業
• 收益與補助
• 未來展望

第4章 受注目的領域

• 藥物亂用試驗
• 毒性檢查
• 醫藥品業界的臨床試驗
• 重金屬、微量元素、溶劑分析
• 糖尿病檢查
• 分子診斷檢查
• 心臟標記
• 血液銀行篩檢
• 基因檢查
• 預防醫學檢查
• 個人化醫療
• 癌症檢查
• 細胞癌症檢查
• 監控技術
• 解剖病理學檢查

第5章 重要的技術動向

• 重點照護檢驗的技術平台的創新
• 新範例
• 工作站的整合
• 自動化
• 實驗室資訊系統
• 新的用戶友善介面
• 資料管理問題

第6章 臨床試驗分析裝置以及試劑市場的商業動向

• 主要市場的發展
• 部門的整合
• 收購價格
• 近年的交易
• 收購、專利契約、社內研發、合作
• 合併、收購、融資、合作
• Quest與LacCorp的比較
• 針對臨床試驗室業務的規範
• 醫院擴展計劃
• 供應鏈與GPO契約
• 特殊試驗室
• 管理照護

第7章 企業檔案資料

第8章 臨床試驗室檢查部門的動向與預測

• 居家照護分析
• 試驗室的非傳統形收集
• 針對急救醫療以及近病患端檢驗的新系統
• 往預防醫學的轉移
• 診斷企業的合併
• 資訊管理的進步
• 檢驗下單模式
• 病患的滿意度
• 從中央試驗室的離開
• 醫療成本管理
• 服務競爭
• 臨床試驗的促進因素與阻礙
• 新技術的影響
• 新動向

第9章 臨床試驗室的商業策略

• 策略1：收購
• 策略2：平行商業發展
• 策略3：試驗室規模擴大
• 策略4：特殊檢查領域的發展
• 策略5：市場行銷
• 策略6：臨床試驗市場上獨立地位的確立
• 策略7：以提供醫療資訊來領導
• 策略8：技術差異化
• 策略9：品質提高
• 策略10：病患對應的提升

附錄

目錄

Abstract

Clinical laboratory testing is generally categorized as either of two general areas--clinical testing and anatomical pathology testing. Clinical and anatomical pathology procedures are frequently ordered as part of regular physician office visits and hospital admissions in connection with the diagnosis and treatment of illnesses. As such, clinical laboratory analysis is one of the most important sections of medical care. The purpose of this TriMark Publications report is to describe the specific segments of the clinical laboratory analysis business. The emphasis in this review is on those companies that are actively developing and marketing laboratory data for the clinical setting, including hospitals, independent labs, physician' s offices and miscellaneous clinics. This study concentrates on the clinical laboratory industry in the U.S. It defines the dollar volume of sales in each major market and analyzes the factors that influence the size and the growth of the individual market segments. The study surveys some of the primary companies known to be marketing clinical laboratory data into the market. Each company is discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market.

The report attempts to answer the questions:

• What companies are the key players?
• What are the opportunities in clinical laboratory testing?
• What is happening with the information revolution?
• What are the development trends?
• Where are the new market growth areas?

This examination reviews the market for clinical laboratory data used in clinical practice. It defines the dollar volume of sales in each major market and analyzes the factors that influence the size and the growth of the individual market segments. The report details market sizes and growth rates for the U.S. and world markets. The study surveys some of the primary companies known to be marketing clinical laboratory data into the market. Each company is discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market.

Unique benefits of this report are:

• In-depth analysis of the major sectors of the clinical laboratory business sector, their size, growth rates and major drivers.
• Presentation of some of the emerging business practices, elucidating the potential areas that could gain traction in this market.
• Analysis of the partnerships and alliances the various key sector players have forged, as well as describing financings of these market participants, giving insight into potential market collaborations.
• Examination of new business methods for clinical laboratories to identify lead positions and potential future growth areas.
• The reader will gain an understanding of key areas of the clinical laboratory testing business.
• New ways to adapt technology innovations and create new revenue streams.
• Sales and marketing strategies that will improve net income.
• Which diagnostic tests are emerging as high profit products.
• Transition to a consumer-based lab model.
• Financial underpinnings of entrepreneurial labs.
• Networking opportunities.
• Insights into the boomer emerging market and their growing expenditures on healthcare.
• Increased merger and acquisition (M&A) activity.
• Shift to preventative medicine.
• Point of care testing.
• Elements of personalized medicine, genetic testing and pharmacogenomics.

Report Statistics

• Publication Date: 01-APR-10
• Pages: 117
• Format: PDF document

Table of Contents

1. Overview

• 1.1 Objectives of the Report
• 1.2 Methodology
• 1.3 Scope of the Report
• 1.4 Executive Summary

2. IVD Clinical Laboratory Market

• 2.1 Introduction
• 2.2 Key Players for Independent Clinical Labs
• 2.3 Medical Expenditures
• 2.4 Medicare Clinical Lab Services Spending Trends

3. The Clinical Laboratory Testing Market

• 3.1 U.S. Market
  • 3.1.1 Hospital-based Clinical Laboratories
  • 3.1.2 Commercial Clinical Laboratory Testing
  • 3.1.3 Physician Office Laboratories (POLs)
• 3.2 Clinical Lab Testing Key Players
  • 3.2.1 Commercial Clinical Labs
  • 3.2.2 Hospital Lab Collaborative Ventures
  • 3.2.3 Specialty Labs
• 3.3 Revenue and Reimbursement
• 3.4 Outlook for Clinical Laboratory Testing
  • 3.4.1 Long-term Changes
  • 3.4.2 Market Drivers
  • 3.4.3 Barriers to Successful Clinical Laboratory Operations
  • 3.4.4 Key Technologies
  • 3.4.5 Conclusion

4. Hot Sectors in the Clinical Lab Testing Market

• 4.1 Workplace Drugs-of-Abuse Testing
• 4.2 Clinical Toxicology
• 4.3 Clinical Testing for the Pharmaceutical Industry
• 4.4 Heavy Metal, Trace Element, and Solvent Analyses
• 4.5 Diabetes (Glucose) Testing
• 4.6 Molecular Diagnostic Testing
• 4.7 Cardiac Markers
• 4.8 Blood Bank Screening
• 4.9 Genetic Testing
• 4.10 Predictive Medicine Testing
• 4.11 Personalized Medicine
• 4.12 Cancer Testing
• 4.13 Cell-based Cancer Testing
• 4.14 Monitoring Technologies
• 4.15 Anatomic Pathology

5. Important Technology Trends

• 5.1 Technology Platform Innovations in Point-of-Care Testing
• 5.2 The New Paradigm
• 5.3 Consolidated Workstations
• 5.4 Automation in the Laboratory
• 5.5 Laboratory Information Systems
• 5.6 New User-friendly Interface
• 5.7 Data-Management Issues
  • 5.7.1 Wireless LANs
  • 5.7.2 Data and Workflow Management Systems
  • 5.7.3 Beckman Central Command
  • 5.7.4 Clinical IT More Widely Available in Physician Practices
  • 5.7.5 Physician Electronic Health Records (EHRs)
  • 5.7.6 Specimen Tracking and Processing

6. Business Trends in the Clinical Laboratory Testing Sector

• 6.1 Key Developments
• 6.2 Sector Consolidation
• 6.3 Acquisition Pricing
• 6.4 A Closer Look at Recent Lab Deals
• 6.5 Acquisition, License Agreements, Internal Development and Partnerships
• 6.6 Merger, Acquisition, Financing and Partnering Activities in the Clinical Lab Industry
• 6.7 Comparison of Quest and LabCorp
  • 6.7.1 Acquisitions
  • 6.7.2 Quest' s Growth
  • 6.7.3 Laboratory Corporation of America
  • 6.7.4 LabCorp' s Growth
  • 6.7.5 Competitive Advantages of National Labs like Quest and LabCorp
  • 6.7.6 National Managed Care Companies
  • 6.7.7 Billing and Collection Management
  • 6.7.8 Lower Reagent and Supply Costs
  • 6.7.9 Esoteric Testing Capabilities
  • 6.7.10 Ability to Invest in Web-based Connectivity Solutions
  • 6.7.11 Competitive Disadvantages of Quest and LabCorp
  • 6.7.12 Difficulties with Turnaround Times and Stat Services
  • 6.7.13 Physician-Laboratory Communication
  • 6.7.14 Specimen Pickup Scheduling Inflexibility
• 6.8 Regulation of Clinical Laboratory Operations
  • 6.8.1 CLIA and State Regulations
  • 6.8.2 Drug Testing
  • 6.8.3 Controlled Substances
  • 6.8.4 Medical Waste, Hazardous Waste and Radioactive Materials
  • 6.8.5 FDA
  • 6.8.6 Occupational Safety
  • 6.8.7 Specimen Transportation
  • 6.8.8 Corporate Practice of Medicine
• 6.9 Hospital Outreach Programs
• 6.10 Supply Chain and GPO Contracting
• 6.11 Specialty Labs
• 6.12 Expansion of Hospital-based Labs and Hospital Outreach Programs
• 6.13 Managed Care

7. Company Profiles

• 7.1 ACM Medical Laboratory
• 7.2 American Esoteric Laboratories (Sonic Healthcare)
• 7.3 American Pathology Partners
• 7.4 AmeriPath (Quest)
• 7.5 ARUP Laboratories
• 7.6 Athena Diagnostics (Thermo Fisher Scientific)
• 7.7 Aurora Diagnostics
• 7.8 Bio-Reference Laboratories, Inc.
• 7.9 BioTech Labs (Laboratory Partners)
• 7.10 CBLPath, Inc.
• 7.11 Centrex Clinical Laboratories, Inc.
• 7.12 Clarient, Inc.
• 7.13 Clinical Laboratories of Hawaii, LLP (Sonic Healthcare)
• 7.14 Clinical Reference Laboratory
• 7.15 Clongen Laboratories, LLC
• 7.16 CompuNet Clinical Laboratories, LLC
• 7.17 Diagnostic Systems Laboratories (Beckman Coulter, Inc.)
• 7.18 Enzo Biochem, Inc.
• 7.19 Esoterix
• 7.20 Focus Diagnostics
• 7.21 Fresenius Medical Care AG & Co. KGaA
• 7.22 Geneva Laboratories
• 7.23 Genomic Health, Inc.
• 7.24 Genzyme
• 7.25 Integrated Regional Laboratories (IRL)
• 7.26 LabCorp
• 7.27 LifeLabs
• 7.28 MEDTOX Scientific, Inc.
• 7.29 Meriter Health Services
• 7.30 Mid America Clinical Laboratories (MACL)
• 7.31 Monogram Biosciences, Inc.
• 7.32 Myriad Genetics, Inc.
• 7.33 National Jewish Medical and Research Center
• 7.34 Parkway Clinical Laboratories
• 7.35 Pathology Associates Medical Laboratories (PAML)
• 7.36 Psychemedics Corporation
• 7.37 Quest Diagnostics, Inc.
• 7.38 RDL Reference Laboratory
• 7.39 Satellite Laboratory Services
• 7.40 Spectrum Laboratory Network
• 7.41 Sonic Healthcare
• 7.42 ViraCor-IBT Laboratories

8. Clinical Laboratory Testing Sector Trends and Forecasts

• 8.1 Home Care Analysis
• 8.2 Non-Traditional Collection for Laboratory Testing
• 8.3 New Systems for Critical-Care and Near-Patient Testing
• 8.4 Shift to Preventative Medicine
• 8.5 Mergers of Diagnostic Companies
• 8.6 Information Management Advances
• 8.7 Test Ordering Patterns
• 8.8 Patient Satisfaction
• 8.9 Move Away from Central Laboratory
• 8.10 Healthcare Cost Controls
• 8.11 Competition for Services
• 8.12 Drivers and Barriers of Clinical Laboratory Testing
• 8.13 Confluence of New Technology
• 8.14 New Trends in Clinical Laboratory Testing
  • 8.14.1 Trends in Reimbursement Practices
  • 8.14.2 Managed Care
  • 8.14.3 Point of Care Testing
  • 8.14.4 Satellite Facilities
  • 8.14.5 Billing Practices

9. Key Clinical Lab Business Strategies

• 9.1 Strategy 1: Acquisitions
• 9.2 Strategy 2: Parallel Businesses Development
• 9.3 Strategy 3: Larger Labs
• 9.4 Strategy 4: Develop Specialty Areas of Testing
• 9.5 Strategy 5: Marketing
• 9.6 Strategy 6: Capitalize on a Unique Position within the Clinical Testing Market
• 9.7 Strategy 7: Lead in Providing Medical Information
• 9.8 Strategy 8: Scientific Differentiation
• 9.9 Strategy 9: Drive Quality
• 9.10 Strategy 10: Deliver a Superior Patient Experience

Appendix 1: Reference Laboratory Directory

Appendix 2: Current List of Laboratories which Meet Minimum Standards to Engage in Urine Drug Testing for Federal Agencies

Appendix 3: FDA/CLIA-Currently Waived Analytes

INDEX OF FIGURES

• Figure 2.3: Part B Spending on Clinical Laboratory Services, 1991-2007
• Figure 3.1: Lab Revenue by Lab Type
• Figure 3.2: Lab Revenue by Test Type
• Figure 3.3: Number of New Tests Granted CLIA-waived Status, 2000-2008
• Figure 3.4: High-Volume Waived Tests
• Figure 5.1: Percentage of Physicians in Practices with IT for Specific Clinical Activities
• Figure 8.1: Reimbursement Distribution for Clinical Lab Service Payers

INDEX OF TABLES

• Table 2.1: Drivers for Overall Medicare Spending
• Table 2.2: Medicare Part B Expenditures, 1970-2008
• Table 2.3: Projections of Medicare Part B Expenditures, 2009-2080
• Table 2.4: Medicare Spending for Clinical Lab Services, 2000-2009
• Table 3.1: U.S. Clinical Laboratory Testing Sector Revenue, 2005-2015
• Table 3.2: U.S. Clinical Laboratory Testing Sector Segments, 2009
• Table 3.3: Esoteric Tests Performed in the Clinical Laboratory
• Table 3.4: Growth Rates of Test Types
• Table 3.5: Drivers of Clinical Lab Testing Volume
• Table 3.6: Independent Commercial Laboratory Testing Test Volume, 2005-2015
• Table 3.7: Physician Office Laboratories Tests
• Table 3.8: Revenue at Leading Publicly-traded Lab Companies, 2009
• Table 3.9: Payer Group Percentage of Total Volume of Requisitions and Net Revenues
• Table 3.10: Barriers to Successful Clinical Lab Operations
• Table 5.1: Applications for Wireless LAN Technology
• Table 6.1: Major Managed Care Players for Clinical Laboratory Services
• Table 6.2: Drivers for Managed Care Spending for Clinical Laboratory Services
• Table 6.3: Revenue for Quest Diagnostics, 2000-2009
• Table 6.4: Revenue for LabCorp, 2000-2009
• Table 6.5: Clinical Lab Quality Assurance Programs
• Table 8.1: Key Elements of Clinical Lab Service
• Table 8.2: Key Competitive Activities for Clinical Lab Service
• Table 8.3: Challenges to the Clinical Lab Testing Industry
• Table 8.4: Medicare Billing Guidelines for Multi-channel Clinical Laboratory Tests
• Table 8.5: Factors for Estimating Collectibility for Clinical Lab Services
• Table 8.6: Classes of Lab Service Payers
• Table 8.7: U.S. POCT Market, 2000-2012
• Table 8.8: U.S. POCT by Performance Location, 2008
• Table 8.9: Billing Difficulties Required of Clinical Labs to Bill Third Party Payers

相關商品

體外診斷設備相關市場調查報告書

全球切片設備市場:開發平台分析，競爭環境，到2018年為止的市場預測
Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
價格 : US $ 3995
出版日期 : 2012年04月

全球分子診斷市場:各國的設施·檢驗數量·銷售額預測
2012 World Molecular Diagnostics Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country
價格 : US $ 1850
出版日期 : 2012年04月

全球微生物測試市場展望：成長機會及業務拓展策略
2012 Microbiology Testing Market Outlook: Growth Opportunities and Strategies
價格 : US $ 28700
出版日期 : 2012年04月

Trimark Publications發行的醫療設備相關市場調查報告書

個人化醫療與癌症治療上的搭配診斷

Companion Diagnostics in Personalized Medicine and Cancer Therapy

價格 : US $ 3400

出版日期 : 2012年02月

血糖值檢驗及糖尿病管理

Blood Glucose Testing and Diabetes Management

價格 : US $ 3400

出版日期 : 2012年02月

全球醫護站診斷檢驗市場

Point of Care Diagnostic Testing World Markets

價格 : US $ 3400

出版日期 : 2012年02月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!